Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Neonatology ; 113(3): 269-274, 2018.
Article in English | MEDLINE | ID: mdl-29393277

ABSTRACT

BACKGROUND: Phototherapy (PT) is widely used to prevent and treat severe hyperbilirubinemia and its associated risks for both acute and chronic bilirubin encephalopathy. Intensive PT, recommended for inpatient treatment of hyperbilirubinemia in term and near-term infants, is defined as having a spectral irradiance of ≥30 µW/cm2/nm. OBJECTIVES: We aimed to assess local PT practices by measuring the irradiance of PT devices in local neonatal intensive care units and newborn nurseries. METHODS: The irradiance footprint, including maximum irradiance at the center of the footprint, of 39 PT devices in 7 area hospitals was measured according to current practice in these facilities. RESULTS: The mean ± SD (range) footprint irradiance was 20.7 ± 5.8 (8.8-29.4) µW/cm2/nm. The mean ± SD maximum irradiance at the footprint center for all devices at a mean clinically used treatment distance of 33.1 ± 9.3 (25.5-60.0) cm was 27.8 ± 7.0 (14.7-42.0) µW/cm2/nm. Sixty-two percent of the devices did not meet the minimum recommended spectral irradiance for intensive PT. For the sites without irradiance-based protocols, the maximum irradiance of the devices (n = 33) at the treatment distances was 25.8 ± 6.1 µW/cm2/nm. CONCLUSIONS: Despite established PT guidelines, local protocols and practices vary. Based on an assessment of 7 local hospitals, intensive PT was suboptimal for 62% of devices. Straightforward changes, such as decreasing the distance between an infant and the light source and establishing a consistent irradiance-based protocol, could substantially improve the quality of the intervention.


Subject(s)
Phototherapy/instrumentation , Humans , Hyperbilirubinemia, Neonatal/therapy , Infant, Newborn , Intensive Care Units, Neonatal/standards , Phototherapy/standards , Professional Practice/standards , Radiometry/methods , Reproducibility of Results , United States
2.
J Child Neurol ; 32(6): 533-536, 2017 05.
Article in English | MEDLINE | ID: mdl-28116951

ABSTRACT

The authors present a case of diffuse intrinsic pontine glioma presenting in a newborn with stridor and respiratory distress that progressed to respiratory failure. Magnetic resonance imaging (MRI) of the brain revealed findings compatible with the diagnosis of diffuse intrinsic pontine glioma. The family pursued palliative care and postmortem examination confirmed WHO grade III astrocytoma.


Subject(s)
Brain Stem Neoplasms/complications , Glioma/complications , Respiratory Insufficiency/etiology , Brain Stem Neoplasms/diagnostic imaging , Diagnosis , Glioma/diagnostic imaging , Humans , Infant, Newborn , Magnetic Resonance Imaging , Male , Respiratory Insufficiency/diagnostic imaging , S100 Proteins/metabolism
3.
Clin Perinatol ; 43(2): 355-73, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27235213

ABSTRACT

Cholestasis in preterm infants has a multifactorial etiology. Risk factors include degree of prematurity, lack of enteral feeding, intestinal injury, prolonged use of parenteral nutrition (PN), and sepsis. Soy-based parenteral lipid emulsions have been implicated in the pathophysiology of PN-associated liver injury. Inflammation plays an important role. Medical therapies are used; however, their effects have not consistently proven effective. Evaluation of cholestasis involves laboratory work; direct bilirubin levels are used for diagnosis and trending. Adverse outcomes include risk for hepatobiliary dysfunction, irreversible liver failure, and death. Early enteral feedings as tolerated is the best way to prevent and manage cholestasis.


Subject(s)
Cholestasis/epidemiology , Enterocolitis, Necrotizing/epidemiology , Fat Emulsions, Intravenous/therapeutic use , Gestational Age , Parenteral Nutrition/statistics & numerical data , Sepsis/epidemiology , Anti-Bacterial Agents/therapeutic use , Antifungal Agents/therapeutic use , Cephalosporins/therapeutic use , Cholestasis/prevention & control , Enteral Nutrition , Fluconazole/therapeutic use , Gastrointestinal Diseases/epidemiology , Humans , Infant, Newborn , Infant, Premature , Risk Factors , Severity of Illness Index
4.
BMC Pediatr ; 15: 184, 2015 Nov 14.
Article in English | MEDLINE | ID: mdl-26572859

ABSTRACT

BACKGROUND: To determine the comprehensiveness of neonatal resuscitation documentation and to determine the association of various patient, provider and institutional factors with completeness of neonatal documentation. METHODS: Multi-center retrospective chart review of a sequential sample of very low birth weight infants born in 2013. The description of resuscitation in each infant's record was evaluated for the presence of 29 Resuscitation Data Items and assigned a Number of items documented per record. Covariates associated with this Assessment were identified. RESULTS: Charts of 263 infants were reviewed. The mean gestational age was 28.4 weeks, and the mean birth weight 1050 g. Of the infants, 69 % were singletons, and 74 % were delivered by Cesarean section. A mean of 13.2 (SD 3.5) of the 29 Resuscitation Data Items were registered for each birth. Items most frequently present were; review of obstetric history (98 %), Apgar scores (96 %), oxygen use (77 %), suctioning (71 %), and stimulation (62 %). In our model adjusted for measured covariates, the institution was significantly associated with documentation. CONCLUSIONS: Neonatal resuscitation documentation is not standardized and has significant variation. Variation in documentation was mostly dependent on institutional factors, not infant or provider characteristics. Understanding this variation may lead to efforts to standardize documentation of neonatal resuscitation.


Subject(s)
Documentation/standards , Infant, Very Low Birth Weight , Medical Records/standards , Resuscitation , Gestational Age , Humans , Infant, Newborn , Intensive Care Units, Neonatal , North America , Retrospective Studies
5.
J Trop Pediatr ; 60(3): 264-6, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24415750

ABSTRACT

Neonatal hyperbilirubinemia continues to be a leading cause of morbidity and mortality in resource-limited countries. The aim of this study was to measure the effectiveness of existing phototherapy units at a local hospital in Cameroon using an irradiance meter. Phototherapy units (n = 4) in one newborn nursery in Cameroon were evaluated. The average irradiance of the functioning units was 2.87 µW/cm(2)/nm, which is substantially below the recommended range of 10-30 µW/cm(2)/nm. With simple improvements, one new prototype unit was developed. Its irradiance was 23.3 µW/cm(2)/nm. We concluded that irradiance of phototherapy units should be measured, as many local nurseries worldwide may not be delivering effective treatment. Simple and cost-effective changes to phototherapy units can make a substantial improvement in irradiance.


Subject(s)
Hyperbilirubinemia, Neonatal/therapy , Phototherapy/instrumentation , Bilirubin/metabolism , Cameroon , Hospitals , Humans , Infant, Newborn , Intensive Care Units, Neonatal/standards , Phototherapy/standards , Radiometry/methods , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...